IgAN
3
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
3
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2025
2026
2027
2028
2029
Sitala BioSTL303
Fosun PharmaFXS6837 Dose 1
ADARx PharmaceuticalsADX-038 Dose Level 2
Clinical Trials (3)
Total enrollment: 120 patients across 3 trials
Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy
Start: Jun 2026Est. completion: Sep 202715 patients
Phase 2Not Yet Recruiting
FXS6837 for the Treatment of IgAN Patients
Start: Mar 2026Est. completion: Nov 202760 patients
Phase 2Not Yet Recruiting
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Start: Aug 2025Est. completion: Jun 202945 patients
Phase 2Recruiting
Related Jobs
Associate Director, U.S. Patient Marketing, IgAN
Boston - MA, US
2w ago
$151K - $227K/yr
Field Reimbursement Manager - Kidney (Pacific Northwest - WA, OR, ID, WY, MT, AK)
United States - Field Based; Wyoming - Field Based; Oregon - Field Based; Montana - Field Based; Idaho - Field Based; Alaska - Field Based; Washington - Field Based
3w ago
$136K - $204K/yr
Field Reimbursement Manager - Kidney (Tri-State - NY, PA, NJ)
United States - Field Based; New York - Field Based; Pennsylvania - Field Based; New Jersey - Field Based
3w ago
$136K - $204K/yr
Field Reimbursement Manager - Kidney (New England - ME, VT, NH, MA, RI, CT)
United States - Field Based; Maine - Field Based; Connecticut - Field Based; Massachusetts - Field Based; Rhode Island - Field Based; New Hampshire - Field Based; Vermont - Field Based
3w ago
$136K - $204K/yr
Field Reimbursement Manager - Kidney (Atlanta, GA, SC)
United States - Field Based; South Carolina - Field Based; Alabama - Field Based; Georgia - Field Based
3w ago
$136K - $204K/yr
Field Reimbursement Manager - Kidney (NJ-MD-DE)
United States - Field Based; Maryland - Field Based; Delaware - Field Based; Pennsylvania - Field Based; New Jersey - Field Based
3w ago
$136K - $204K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 120 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.